Related Experiment Video
Updated: Aug 20, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
[Vascular risk factors and renal failure]
1Centre de recherche et service de néphrologie, Hôpital du Sacré-Coeur de Montréal, Université de Montréal, 5400, boulevard Gouin Ouest, Montréal, Québec, H4J 1C5 Canada. f-madore@crhsc.umontreal.ca
Insights
Patients with chronic kidney disease (CKD) face higher cardiovascular disease (CVD) risks due to traditional factors and uremia-related issues like inflammation and oxidant stress. This review explores these non-traditional risks in CKD patients.
Area of Science:
- Nephrology
- Cardiology
- Pathophysiology
Context:
- Chronic kidney disease (CKD) significantly elevates cardiovascular disease (CVD) risk.
- Traditional atherosclerosis risk factors (diabetes, hypertension, dyslipidemia) are highly prevalent in CKD patients.
- Accelerated vascular disease is a major concern in CKD populations.
Purpose:
- To review current knowledge on non-traditional, uremia-related risk factors for atherosclerosis in CKD.
- To emphasize the role of inflammation and oxidant stress in CKD-related CVD.
- To discuss the prevalence, cardiac risk, and management of these factors in CKD.
Summary:
- CKD patients exhibit increased CVD risk beyond traditional factors.
- Uremia-related factors, including inflammation and oxidant stress, contribute to atherosclerosis pathogenesis.
- Evidence over 15 years highlights these non-traditional risk factors in renal failure.
Impact:
- Informs clinical understanding of CVD in CKD.
- Guides research into novel therapeutic targets for CKD-related cardiovascular complications.
- Aids in developing comprehensive management strategies for CKD patients at high cardiac risk.
Abstract:
Patients with chronic kidney disease (CKD) have a substantially increased risk of cardiovascular disease (CVD) compared with the general population. The high prevalence of established traditional risk factors for atherosclerosis (diabetes, hypertension, dyslipidemia) in these patients undoubtedly contributes to the accelerated rate of vascular disease. In addition, several hypotheses have emerged to explain the high prevalence of CVD in patients with chronic renal failure. Growing evidence has been gathered over the last 15 years regarding the role of uremia-related risk factors such as inflammation and oxidant stress in the pathogenesis of atherosclerosis in subjects with renal failure. This paper will review current knowledge regarding the potential role of these non-traditional or uremia-related risk factors for atherosclerosis with special emphasis on prevalence, cardiac risk, and management in patients with CKD.
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Heart Failure Drugs: Diuretics
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute Kidney Injury II: Pathophysiology
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration